Literature DB >> 22743039

Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution.

Akiyoshi Kasuga1, Akiko Chino, Naoyuki Uragami, Teruhito Kishihara, Masahiro Igarashi, Rikiya Fujita, Noriko Yamamoto, Masashi Ueno, Masatoshi Oya, Tetsuichiro Muto.   

Abstract

BACKGROUND AND AIM: A treatment strategy for tumors with only venous invasion and characteristics of small rectal carcinoids with metastasis have not been clearly documented. The present study aims to determine the risk factors for lymph node metastasis and to elucidate characteristics of small tumors with metastasis.
METHODS: We investigated a total of 229 patients with rectal carcinoids. The relationship between each clinicopathological variable and the presence of lymph node metastasis was evaluated.
RESULTS: Tumor size (larger than 10 mm), presence of central depression, depth of tumor invasion, lymphatic invasion, and venous invasion were significantly associated with the incidence of lymph node metastasis (P < 0.001). Multivariate analysis revealed that tumor size (odds ratio: 63.3, P < 0.001) and venous invasion (odds ratio: 40.9, P < 0.001) were independently predictive of lymph node metastasis. In 204 patients with small (no larger than 10 mm) tumors, 10 patients had lymph node metastasis. All 10 tumors had low proliferation values indicated by mitosis and Ki-67 index. Multivariate analysis for the 204 patients revealed that only venous invasion was independently associated with metastasis (odds ratio: 40.1, P < 0.001). Five-year disease free survival rates of the total patients with metastasis and without metastasis were 81.1% and 95.5%, respectively (P < 0.001, log-rank test).
CONCLUSIONS: Venous invasion as well as tumor size and lymphatic invasion indicates high malignant potential to metastasize to lymph node and would provide useful information in considering the addition of radical surgery. Postoperative pathological examinations of specimens obtained by local resection are very important to avoid underestimation.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22743039     DOI: 10.1111/j.1440-1746.2012.07218.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  28 in total

1.  Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.

Authors:  Masau Sekiguchi; Shigeki Sekine; Taku Sakamoto; Yosuke Otake; Takeshi Nakajima; Takahisa Matsuda; Hirokazu Taniguchi; Ryoji Kushima; Yuichiro Ohe; Yutaka Saito
Journal:  J Gastroenterol       Date:  2015-05-05       Impact factor: 7.527

2.  Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.

Authors:  Yusuke Nishikawa; Akiko Chino; Daisuke Ide; Shoichi Saito; Masahiro Igarashi; Manabu Takamatsu; Junko Fujisaki; Yoshinori Igarashi
Journal:  Int J Colorectal Dis       Date:  2019-10-19       Impact factor: 2.571

3.  Clinical impact of atypical endoscopic features in rectal neuroendocrine tumors.

Authors:  Jong Hee Hyun; Seong Dae Lee; Eui Gon Youk; Jae Bum Lee; Enu-Jung Lee; Hee Jin Chang; Dae Kyung Sohn
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

4.  Resection of multiple rectal carcinoids with transanal endoscopic microsurgery: case report.

Authors:  Jiao-Lin Zhou; Guo-Le Lin; Da-Chun Zhao; Guang-Xi Zhong; Hui-Zhong Qiu
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

5.  Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.

Authors:  Yihebali Chi; Feng Du; Hong Zhao; Jin-Wan Wang; Jian-Qiang Cai
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 6.  Rectal carcinoids: a systematic review.

Authors:  Frank D McDermott; Anna Heeney; Danielle Courtney; Helen Mohan; Des Winter
Journal:  Surg Endosc       Date:  2014-03-01       Impact factor: 4.584

7.  Outcomes for a Large Cohort of Patients with Rectal Neuroendocrine Tumors: an Analysis of the National Cancer Database.

Authors:  Beiqun Zhao; Hannah M Hollandsworth; Nicole E Lopez; Lisa A Parry; Benjamin Abbadessa; Bard C Cosman; Sonia L Ramamoorthy; Samuel Eisenstein
Journal:  J Gastrointest Surg       Date:  2020-02-03       Impact factor: 3.452

Review 8.  Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis.

Authors:  Xin Zhou; Haiting Xie; Lingduo Xie; Jing Li; Wei Fu
Journal:  J Gastrointest Surg       Date:  2013-07-02       Impact factor: 3.452

Review 9.  [Rectal neuroendocrine tumors: surgical therapy].

Authors:  O Radulova-Mauersberger; S Stelzner; H Witzigmannn
Journal:  Chirurg       Date:  2016-04       Impact factor: 0.955

10.  Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.

Authors:  Chang Mo Moon; Kyu Chan Huh; Sung-Ae Jung; Dong Il Park; Won Hee Kim; Hye Mi Jung; Seong-Joon Koh; Jin-Oh Kim; Yunho Jung; Kyeong Ok Kim; Jong Wook Kim; Dong-Hoon Yang; Jeong Eun Shin; Sung Jae Shin; Eun Soo Kim; Young-Eun Joo
Journal:  Am J Gastroenterol       Date:  2016-07-05       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.